Compared with other neuropsychiatric illnesses, most studies on the effects of GLP-1RAs in psychotic disorders seem to have focused so far on their potential use to counteract the cardiometabolic side effects due to antipsychotic medications
Series B, Biological Sciences, 361, 11871209
Several trials, such as the United Kingdom Prospective Diabetes Study (UKPDS) and Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE), have demonstrated that appropriate control of blood glucose is beneficial for the reduction of long-term cardiovascular complications [4, 5]
Diabetes, oncology, respiratory diseases, and neurology remain dominant segments
May not combine offers or promotions